Prevalence of QT interval prolongation in inflammatory bowel disease

Deepak J Pattanshetty1, Rama Dilip Gajulapalli, Kiran Anna

  • 1Department of Heart and Vascular Center, MetroHealth Campus of Case Western Reserve University, Cleveland, USA. deepakPJ@yahoo.com.

Insights

Patients with inflammatory bowel disease (IBD) face a higher risk of QT interval prolongation, a condition linked to dangerous heart rhythms. This study highlights the need for cardiac risk assessment in IBD patients.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Pharmacology

Background:

  • Inflammatory bowel disease (IBD) is associated with increased cardiac risks.
  • Factors like chronic inflammation, electrolyte imbalances, and medications (e.g., Infliximab) contribute to QT interval prolongation in IBD.
  • QT interval prolongation is a known risk factor for malignant ventricular arrhythmias.

Purpose of the Study:

  • To determine the prevalence of abnormal QT interval prolongation in patients with inflammatory bowel disease.
  • To identify potential risk factors for QT interval prolongation within the IBD population.

Main Methods:

  • Retrospective chart review of 142 IBD patients from a hospital database.
  • Analysis of demographic characteristics and laboratory data.
  • Measurement of QT intervals and calculation of corrected QT (QTc) intervals using Bazett's formula from electrocardiograms.

Main Results:

  • Nearly half of IBD patients exhibited prolonged QTc intervals: 42.3% of males and 48.9% of females.
  • Patients with prolonged QTc intervals had a significantly higher body mass index (29.7±6.9) compared to those with normal QTc intervals (26.2±5.9).

Conclusions:

  • The study confirms a higher prevalence of QTc interval prolongation in patients with IBD.
  • Elevated body mass index may be associated with QTc prolongation in this population, warranting further investigation.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
896
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
920
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K